EVO

Evotec SE American Depositary Shares
$3.07 0.00%

Recent alerts on EVO

All signals →
News Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
14d ago
News Novo Nordisk And Evotec Collaborate On Stem Cell-Based Therapy Development
14d ago
News Evotec places €116.1M convertible bonds to fund Project Horizon
20d ago
SEC filing EVO Reports €156.6M Revenue, -22% YoY, Adj. EBITDA €(21.9)M, Confirms 2026 Guidance: €700-780M Revenue, €0-40M Adj. EBITDA
27d ago
SEC filing EVO Reports $1.2B Revenue, $0.15 EPS, +18% YoY, Adds Dr. Wolfgang Hofmann to Board, Expands Supervisory Board to 7 Members, MAK Capital Deal
33d ago
SEC filing EVO Reports €253.3M Q4 Revenue, €788.4M FY Revenue, €58.0M Adj. EBITDA, Launches €75M Cost Savings, Appoints CCO
55d ago
News Gilead Acquisition Spree Continues With $3 Billion Tubulis Deal
56d ago
News Evercore Pauses Offers to Canadian Workers Amid Visa Concerns
124d ago
News Evercore ISI Highlights Dupixent and Eylea HD as Key Growth Drivers For Regeneron Pharmaceuticals, Inc. (REGN)
124d ago
News Antibody Optimization Service (Affinity Maturation, Humanization, Phage Display, AI-based Computational Optimization) Market Trends Analysis and Growth Forecast Report 2025-2033
132d ago
News Evotec Biologics wins grant for AI-driven mAb optimization
145d ago
News Amgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs
146d ago
Scanner Unusual volume (z=18.4)
160d ago
Scanner Unusual volume (z=18.6)
163d ago
Scanner Unusual volume (z=18.6)
164d ago
News MUVON Therapeutics Appoints Dr. Christine Günther as Chief Technology Officer
165d ago
News MUVON Therapeutics Appoints Dr. Christine Günther as Chief Technology Officer
166d ago

Get push alerts for EVO

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS